NMRA logo

NMRA
Neumora Therapeutics Inc.

1,138
Mkt Cap
$344.63M
Volume
503,508.00
52W High
$3.65
52W Low
$0.69
PE Ratio
-1.40
NMRA Fundamentals
Price
$1.86
Prev Close
$1.86
Open
$1.85
50D MA
$2.14
Beta
1.84
Avg. Volume
1.33M
EPS (Annual)
-$1.45
P/B
4.79
Rev/Employee
$0.00
$164.95
Loading...
Loading...
News
all
press releases
Neumora Therapeutics (NMRA) Projected to Post Quarterly Earnings on Monday
Neumora Therapeutics (NASDAQ:NMRA) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-neumora-therapeutics-inc-stock...
News Placeholder
More News
News Placeholder
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are covering the firm, Marketbeat reports...
News Placeholder
Q2 EPS Forecast for Neumora Therapeutics Boosted by Analyst
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Equities researchers at HC Wainwright increased their Q2 2026 earnings per share (EPS) estimates for shares of Neumora Therapeutics in a...
News Placeholder
Guggenheim Reaffirms "Buy" Rating for Neumora Therapeutics (NASDAQ:NMRA)
Guggenheim reiterated a "buy" rating and issued a $14.00 target price on shares of Neumora Therapeutics in a report on Tuesday...
News Placeholder
Neumora Therapeutics' (NMRA) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and issued a $8.00 price objective on shares of Neumora Therapeutics in a research note on Tuesday...
News Placeholder
Neumora Therapeutics Sees Unusually Large Options Volume (NASDAQ:NMRA)
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) was the recipient of some unusual options trading on Monday. Traders bought 2,812 call options on the company. This represents an increase of 309% compared to the typical daily volume of 687 call options...
News Placeholder
Neumora Therapeutics Q4 Earnings Call Highlights
Neumora Therapeutics (NASDAQ:NMRA) outlined clinical and pipeline updates alongside its fourth-quarter and full-year 2025 financial results, highlighting multiple anticipated data catalysts in 2026...
News Placeholder
Neumora Therapeutics (NASDAQ:NMRA) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Neumora Therapeutics (NASDAQ:NMRA - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus...
News Placeholder
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) have received a consensus rating of "Hold" from the ten ratings firms that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, one has issued a...
News Placeholder
Neumora Therapeutics Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
read more...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available